Try our beta test site
32 studies found for:    Northwestern AND Crohn's disease
Show Display Options
Rank Status Study
1 Terminated
Has Results
Crohn's Disease Stem Cell Transplantation
Condition: Crohn's Disease
Intervention: Biological: Autologous Stem Cell Transplantation
2 Terminated Non-myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (NST) for Patients With Refractory Crohn's Disease
Condition: Crohn's Disease
Intervention: Biological: Allogeneic Stem Cell Therapy
3 Terminated Hematopoietic Stem Cell Support in Patients With Severe Crohn's Disease
Condition: CROHN'S DISEASE
Intervention: Biological: Immune Ablation and Hematopoietic Stem Cell Support
4 Recruiting Impact of Therapeutic Strategies in the Pediatric Inflammatory Bowel Disease: a Population Based Study (1988-2008).
Condition: Pediatric Inflammatory Bowel Disease
Intervention:
5 Unknown  Manipulation of Visceral Sensitivity and Immune System in IBS
Condition: Irritable Bowel Syndrome
Intervention: Drug: probiotic (bacterial/dietary supplement)
6 Terminated
Has Results
Inositol in Preventing Colorectal Cancer in Patients With Colitis-Associated Dysplasia
Conditions: Colon Carcinoma;   Dysplasia in Crohn Disease;   Low Grade Dysplasia in Ulcerative Colitis;   Rectal Carcinoma
Interventions: Drug: Inositol;   Other: Placebo
7 Completed Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects With Crohn's Disease
Condition: Crohn's Disease
Intervention: Drug: Adalimumab
8 Completed STA-5326 in Crohn's Disease Patients
Condition: Crohn's Disease
Intervention: Drug: STA-5326
9 Completed Semapimod for Treatment of Moderate to Severe Crohn's Disease 1 or 3 Days' Treatment Versus Placebo
Condition: Crohn's Disease
Interventions: Drug: Semapimod;   Drug: Placebo
10 Completed Long-term Study of Semapimod (CNI-1493) for Treatment of Crohn's Disease
Condition: Crohn's Disease
Intervention: Drug: Semapimod
11 Completed
Has Results
Remission in Subjects With Crohn's Disease, Open Label Extension
Condition: Crohn's Disease
Intervention: Biological: Adalimumab 40 mg eow or ew
12 Terminated CNI-1493 for Treatment of Moderate to Severe Crohn's Disease
Condition: Crohn Disease
Interventions: Drug: semapimod;   Drug: placebo
13 Completed Extension Study of Semapimod 60 mg IV x 3 Days
Condition: Crohn's Disease
Intervention: Drug: Semapimod
14 Completed
Has Results
Remission in Subjects With Crohn's Disease, 1 Year Phase
Condition: Crohn's Disease
Interventions: Biological: Double-blind (DB) adalimumab placebo;   Biological: DB adalimumab 40 mg eow;   Biological: DB adalimumab 40 mg ew;   Biological: OL adalimumab 40 mg
15 Completed A Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease
Condition: Crohn's Disease
Intervention: Drug: Adalimumab (D2E7)
16 Completed An Efficacy and Safety Study of Omega-3 Free Fatty Acids (Epanova™) for the Maintenance of Symptomatic Remission in Subjects With Crohn's Disease
Condition: Crohn's Disease
Intervention: Drug: Epanova™ (Omega-3 Free Fatty Acids)
17 Unknown  Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Condition: Crohn's Disease
Interventions: Biological: Trichuris suis ova (TSO);   Biological: Placebo
18 Completed Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008
Condition: Crohn Disease
Intervention: Drug: Teduglutide (ALX-0600)
19 Recruiting Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease
Condition: Crohn Disease
Interventions: Drug: GED-0301;   Drug: Placebo
20 Completed Efficacy and Safety of GLPG0634 in Subjects With Active Crohn's Disease
Condition: Crohn's Disease
Interventions: Drug: GLPG0634;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-32) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.